| Active principles | Rating | Bibliogr. | Expand |
---|
1 | Uric Acid | 100 | + | |
2 | Colchicine | 66 | + | |
3 | Neuropilin-2 | 48 | + | |
4 | Allopurinol | 34 | + | |
5 | Oleanolic Acid | 28 | + | |
6 | Drugs, Chinese Herbal | 19 | + | |
7 | Interleukin-1beta | 19 | + | |
8 | Methotrexate | 18 | + | |
9 | Collagen Type II | 15 | + | |
10 | Tumor Necrosis Factor-alpha | 14 | + | |
11 | Receptors, Tumor Necrosis Factor | 14 | + | |
12 | Plant Extracts | 12 | + | |
13 | Rheumatoid Factor | 11 | + | |
14 | Immunoglobulin G | 11 | + | |
15 | Antibodies, Monoclonal | 11 | + | |
16 | Collagen | 10 | + | |
17 | Sulfasalazine | 9 | + | |
18 | Penicillamine | 8 | + | |
19 | Gold Sodium Thiomalate | 8 | + | |
20 | Gold | 7 | + | |
21 | Freund's Adjuvant | 6 | + | |
22 | Hydroxychloroquine | 6 | + | |
23 | Autoantibodies | 6 | + | |
24 | Auranofin | 6 | + | |
25 | Interleukin 1 Receptor Antagonist Protein | 6 | + | |
26 | Isoxazoles | 6 | + | |
27 | Cytokines | 5 | + | |
28 | Interleukin-1 | 5 | + | |
29 | Biological Products | 5 | + | |
30 | Interleukin-6 | 5 | + | |
31 | Matrix Metalloproteinase 3 | 5 | + | |
32 | Antibodies, Monoclonal, Humanized | 5 | + | |
33 | Interleukin-17 | 5 | + | |
34 | Aurothioglucose | 4 | + | |
35 | C-Reactive Protein | 4 | + | |
36 | Sialoglycoproteins | 4 | + | |
37 | Receptors, Interleukin-6 | 4 | + | |
38 | Prednisolone | 4 | + | |
39 | Naproxen | 4 | + | |
40 | Chaperonin 60 | 4 | + | |
41 | Organogold Compounds | 4 | + | |
42 | Glucose-6-Phosphate Isomerase | 4 | + | |
43 | Chaperonins | 4 | + | |
44 | Antibodies | 3 | + | |
45 | Immunoconjugates | 3 | + | |
46 | HLA-B27 Antigen | 3 | + | |
47 | Indomethacin | 3 | + | |
48 | Glucocorticoids | 3 | + | |
49 | HLA-DR4 Antigen | 3 | + | |
50 | Extracellular Matrix Proteins | 3 | + | |
51 | Matrilin Proteins | 3 | + | |
52 | HLA-DRB1 Chains | 3 | + | |
53 | Proteoglycans | 3 | + | |
54 | Antibodies, Monoclonal, Murine-Derived | 3 | + | |
55 | Antigens, CD4 | 3 | + | |
56 | Piroxicam | 3 | + | |
57 | Peptides, Cyclic | 3 | + | |
58 | RANK Ligand | 3 | + | |
59 | Etodolac | 3 | + | |
60 | Immunoglobulin M | 3 | + | |
61 | Serum Amyloid A Protein | 2 | + | |
62 | Recombinant Fusion Proteins | 2 | + | |
63 | Matrix Metalloproteinase 13 | 2 | + | |
64 | Carrageenan | 2 | + | |
65 | Aggrecans | 2 | + | |
66 | HLA-DR Antigens | 2 | + | |
67 | Receptors, Tumor Necrosis Factor, Type II | 2 | + | |
68 | Antigen-Antibody Complex | 2 | + | |
69 | Receptors, Interleukin-1 | 2 | + | |
70 | Calgranulin A | 2 | + | |
71 | Cartilage Oligomeric Matrix Protein | 2 | + | |
72 | Salicylates | 2 | + | |
73 | Serum Albumin, Bovine | 2 | + | |
74 | Janus Kinase 3 | 2 | + | |
75 | Antibodies, Antinuclear | 2 | + | |
76 | Peptidoglycan | 2 | + | |
77 | Matrix Metalloproteinases | 2 | + | |
78 | Interleukin-10 | 2 | + | |
79 | Osteoprotegerin | 2 | + | |
80 | Prednisone | 2 | + | |
81 | Adrenal Cortex Hormones | 2 | + | |
82 | Calgranulin B | 2 | + | |
83 | Zymosan | 2 | + | |
84 | Antibodies, Blocking | 2 | + | |
85 | Diclofenac | 2 | + | |
86 | Methylprednisolone | 2 | + | |
87 | Thiomalates | 2 | + | |
88 | Glycoproteins | 2 | + | |
89 | Phenylpropionates | 2 | + | |
90 | Cyclooxygenase 2 | 2 | + | |
91 | Thienopyridines | 2 | + | |
92 | Metalloendopeptidases | 2 | + | |
93 | Receptors, Tumor Necrosis Factor, Type I | 2 | + | |
94 | Tumor Necrosis Factors | 2 | + | |
95 | Oxidoreductases Acting on CH-CH Group Donors | 2 | + | |
96 | Hydroxymethyl and Formyl Transferases | 2 | + | |
97 | Matrix Metalloproteinase 1 | 2 | + | |
98 | RNA, Messenger | 2 | + | |
99 | Dinoprostone | 2 | + | |
100 | Propionates | 2 | + | |
101 | Polyglutamic Acid | 2 | + | |
102 | Tumor Necrosis Factor Decoy Receptors | 2 | + | |
103 | B-Cell Activating Factor | 2 | + | |
104 | Reduced Folate Carrier Protein | 2 | + | |
105 | Cyclosporine | 2 | + | |
106 | Interferon-gamma | 2 | + | |
107 | Thiazines | 2 | + | |
108 | Indoprofen | 2 | + | |
109 | Immunoglobulins | 1 | + | |
110 | Hyaluronic Acid | 1 | + | |
111 | Gold Compounds | 1 | + | |
112 | Collagenases | 1 | + | |
113 | Prostaglandin-Endoperoxide Synthases | 1 | + | |
114 | Nucleotide Deaminases | 1 | + | |
115 | HLA-DR1 Antigen | 1 | + | |
116 | Immunoglobulin Fc Fragments | 1 | + | |
117 | Citrulline | 1 | + | |
118 | Lymphotoxin-alpha | 1 | + | |
119 | Phenylbutazone | 1 | + | |
120 | Interleukin-18 | 1 | + | |
121 | Hesperidin | 1 | + | |
122 | Interleukin-1alpha | 1 | + | |
123 | Receptors, IgG | 1 | + | |
124 | Macrophage Migration-Inhibitory Factors | 1 | + | |
125 | Membrane Proteins | 1 | + | |
126 | Antibodies, Anti-Idiotypic | 1 | + | |
127 | Complement C3 | 1 | + | |
128 | Flurbiprofen | 1 | + | |
129 | Interleukin-4 | 1 | + | |
130 | Indoleacetic Acids | 1 | + | |
131 | Annexin A1 | 1 | + | |
132 | Receptor Activator of Nuclear Factor-kappa B | 1 | + | |
133 | Chemokines | 1 | + | |
134 | Ibuprofen | 1 | + | |
135 | Steroids | 1 | + | |
136 | NF-kappa B | 1 | + | |
137 | Diamines | 1 | + | |
138 | Sulfapyridine | 1 | + | |
139 | Lipopolysaccharides | 1 | + | |
140 | Peptide Fragments | 1 | + | |
141 | Triamcinolone Acetonide | 1 | + | |
142 | Isoenzymes | 1 | + | |
143 | Butanones | 1 | + | |
144 | Acute-Phase Proteins | 1 | + | |
145 | Osmium Tetroxide | 1 | + | |
146 | Feprazone | 1 | + | |
147 | Lectins, C-Type | 1 | + | |
148 | Phenylacetates | 1 | + | |
149 | Calcium Pyrophosphate | 1 | + | |
150 | Apazone | 1 | + | |
151 | Cathepsins | 1 | + | |
152 | Cytokine Receptor gp130 | 1 | + | |
153 | Recombinant Proteins | 1 | + | |
154 | Pyrazoles | 1 | + | |
155 | Interleukins | 1 | + | |
156 | Immune Sera | 1 | + | |
157 | Bacterial Proteins | 1 | + | |
158 | Osmium | 1 | + | |
159 | Gold Sodium Thiosulfate | 1 | + | |
160 | Tissue Inhibitor of Metalloproteinases | 1 | + | |
161 | alpha 1-Antitrypsin | 1 | + | |
162 | Complement C1 | 1 | + | |
163 | Serum Albumin | 1 | + | |
164 | ortho-Aminobenzoates | 1 | + | |
165 | Chloroquine | 1 | + | |
166 | Sulfhydryl Compounds | 1 | + | |
167 | Glucosamine | 1 | + | |
168 | Epoxy Compounds | 1 | + | |
169 | Receptors, Interleukin-2 | 1 | + | |
170 | Metalloproteases | 1 | + | |
171 | Oncostatin M | 1 | + | |
172 | Thymopentin | 1 | + | |
173 | Terpenes | 1 | + | |
174 | Heat-Shock Proteins | 1 | + | |
175 | Levamisole | 1 | + | |
176 | Phosphines | 1 | + | |
177 | CARD Signaling Adaptor Proteins | 1 | + | |
178 | Receptors, Chemokine | 1 | + | |
179 | Chemokine CCL5 | 1 | + | |
180 | Dexamethasone | 1 | + | |
181 | Diflunisal | 1 | + | |
182 | Receptors, CCR2 | 1 | + | |
183 | Complement C4 | 1 | + | |
184 | Tissue Extracts | 1 | + | |
185 | Peptides | 1 | + | |
186 | Interleukin-23 | 1 | + | |
187 | NFATC Transcription Factors | 1 | + | |
188 | Thymopoietins | 1 | + | |
189 | p38 Mitogen-Activated Protein Kinases | 1 | + | |
190 | Immunoglobulin A | 1 | + | |
191 | Cyanogen Bromide | 1 | + | |
192 | Lyme Disease Vaccines | 1 | + | |
193 | Group IV Phospholipases A2 | 1 | + | |
194 | Indenes | 1 | + | |
195 | Propanols | 1 | + | |
196 | Sulfonamides | 1 | + | |
197 | Antigens, CD44 | 1 | + | |
198 | Acid Phosphatase | 1 | + | |
199 | Microbial Collagenase | 1 | + | |
200 | Membrane Glycoproteins | 1 | + | |
201 | Organic Chemicals | 1 | + | |
202 | Receptors, Antigen, T-Cell, alpha-beta | 1 | + | |
203 | Histocompatibility Antigens Class II | 1 | + | |
204 | Leukotriene B4 | 1 | + | |
205 | Carrier Proteins | 1 | + | |
206 | ADAM Proteins | 1 | + | |
207 | Tissue Inhibitor of Metalloproteinase-1 | 1 | + | |
208 | HLA-DR2 Antigen | 1 | + | |
209 | Glucosides | 1 | + | |
210 | Phosphoribosylaminoimidazolecarboxamide Formyltransferase | 1 | + | |
211 | Arachidonate 5-Lipoxygenase | 1 | + | |
212 | Azathioprine | 1 | + | |
213 | HMGB1 Protein | 1 | + | |
214 | Lymphotoxin-beta | 1 | + | |
215 | Ketoprofen | 1 | + | |
216 | Minocycline | 1 | + | |
217 | Aspirin | 1 | + | |
218 | Matrix Metalloproteinase 9 | 1 | + | |
219 | Receptor, TIE-2 | 1 | + | |
220 | Complement Inactivator Proteins | 1 | + | |
221 | Receptors, CCR1 | 1 | + | |
222 | Lymphotoxin beta Receptor | 1 | + | |
223 | Immunoglobulin Fab Fragments | 1 | + | |
224 | Endodeoxyribonucleases | 1 | + | |
225 | Bufexamac | 1 | + | |
226 | Chemokine CCL2 | 1 | + | |
227 | Lymecycline | 1 | + | |
228 | Blood Proteins | 1 | + | |
229 | I-kappa B Kinase | 1 | + | |
230 | Cloxacillin | 1 | + | |
231 | Indolizines | 1 | + | |
232 | Cell Adhesion Molecules | 1 | + | |
233 | Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | + | |
234 | Tetracyclines | 1 | + | |
235 | Glycosaminoglycans | 1 | + | |
236 | Chondroitin Sulfates | 1 | + | |
237 | Nitric Oxide Synthase Type II | 1 | + | |
238 | Nitric Oxide | 1 | + | |
239 | Receptors, Interleukin-17 | 1 | + | |
240 | Bee Venoms | 1 | + | |
241 | Lectins | 1 | + | |
242 | Clodronic Acid | 1 | + | |
243 | Polysaccharides | 1 | + | |
244 | Receptors, Immunologic | 1 | + | |
245 | Benzomorphans | 1 | + | |
246 | B-Cell Activation Factor Receptor | 1 | + | |
247 | Concanavalin A | 1 | + | |
248 | Follistatin-Related Proteins | 1 | + | |
249 | Chemokines, CXC | 1 | + | |
250 | Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 1 | + | |
251 | Receptors, Leukotriene B4 | 1 | + | |
252 | Prostaglandins | 1 | + | |
253 | Technetium | 1 | + | |
254 | Cathepsin K | 1 | + | |
255 | Cyclooxygenase 1 | 1 | + | |
256 | Immunoglobulin Isotypes | 1 | + | |
257 | Intramolecular Oxidoreductases | 1 | + | |
258 | Matrix Metalloproteinase 8 | 1 | + | |
259 | Complement System Proteins | 1 | + | |
260 | Cyclophilin A | 1 | + | |
261 | Phenanthrenes | 1 | + | |
262 | Histidine | 1 | + | |
263 | Interleukin-8 | 1 | + | |
264 | Nitrites | 1 | + | |
265 | Eicosanoids | 1 | + | |
266 | Radon | 1 | + | |
267 | AMP Deaminase | 1 | + | |
268 | Pokeweed Mitogens | 1 | + | |
269 | Complement C5 | 1 | + | |